Genocea Biosciences reported $-15373000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US USD -39945000 3.34M
Baxter International BAX:US USD 855M 68M
Bluebird Bio BLUE:US USD -85093000 14.32M
Cytokinetics CYTK:US USD -107033000 97.57M
Cytori Therapeutics CYTX:US USD -4936000 29K
Genocea Biosciences GNCA:US USD -15373000 2.37M
Glaxosmithkline GSK:US GBP 3.36B 916M
Infinity Pharmaceuticals INFI:US USD -10770000 1.13M
Mirati Therapeutics MRTX:US USD -185727000 9.22M
Moderna Inc MRNA:US USD 1.28B 1.24B
Pfizer PFE:US USD 10.52B 2.78B